AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
No IPO, but Cell Therapeutics 'public.' (registers 17 million shares with the Securities and Exchange Commission)
Biotech's shares registered with SEC, but won't be listed on any exchange
Thwarted in its plans for a June initial public offering, Cell Therapeutics Inc. is nonetheless becoming a public company.
The Seattle biotechnology company, which has amassed more private financing than any other biotech in the region, has filed with the Securities and Exchange Commission to register the 17 million shares already owned by its 520 stockholders.
That will free those investors to trade Cell Therapeutics shares, and will require the company to submit quarterly and annual reports. It also means the company will bear the burden of SEC compliance and the vicissitudes of the …
-
- Cell Therapeutics IPO shelved; no new date set. (Cell Therapeutics Inc.)
-
Magazine article from: Puget Sound Business Journal
Grunbaum, Rami
June 28, 1996
700+ words
-
- Drug giant walks away from Cell Therapeutics deal. (Schering AG; Cell...
-
Magazine article from: Puget Sound Business Journal
Grunbaum, Rami
May 10, 1996
700+ words
-
- IPO outlook: July 29, 2004.
-
Newspaper article from: The Daily Deal
July 29, 2004
700+ words
-
- "We can achieve value of hundreds of millions of dollars".
-
News wire article from: Asia Africa Intelligence Wire
March 23, 2005
700+ words
-
- Chillier market puts local offerings on ice. (securities offerings)
-
Magazine article from: Puget Sound Business Journal
Grunbaum, Rami Baker, M. Sharon
August 9, 1996
700+ words
